Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Humira Drug Market Evolve in Terms of Growth and Size by 2029?

The market size for the Humira drug has significantly expanded in the past few years. Its growth trend is projected to continue, advancing from $9.74 billion in 2024 to $10.33 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.0%. The escalation experienced during the historic timeframe can be credited to factors such as the advent of biologics, advancements in biotechnology, increasing patient needs for efficacious treatments, and changing physician adoption and prescription trends.

Anticipations are high for a robust expansion in the Humira drug market in the upcoming years, with projections estimating a growth to “$13.93 billion in 2029 with a compound annual growth rate (CAGR) of 7.8%. This surge in the forecast timeline is credited to the entrance of biosimilar markets, alterations in healthcare policies, emphasis on cost-efficiency, research and development investments, along with precision medicine and tailor-made treatment approaches. The prediction period will also witness notable trends including the production of real-world evidence, enlarged usage in young age groups, transition towards self-administrable medications, value-oriented pricing structures, and advancements in targeted therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11934&type=smp

What factors are expected to fuel Humira Drug market growth in the coming years?

The escalating occurrence of autoimmune disease is anticipated to stimulate the expansion of the Humira drug market. An autoimmune disease is a condition in which the immune system of the body targets and destroys healthy tissues and cells. The Humira drug is utilized to alleviate pain and inflammation instigated by numerous autoimmune diseases, therefore, an upsurge in the incidence rate of autoimmune diseases amplifies the need for this drug. For instance, the National Health Council, a non-profit organization located in the U.S, reported in March 2024 that autoimmune diseases affect about 50 million Americans. However, because of the challenges in diagnosing these diseases, this number is probably underestimated. It is even more worrying that autoimmunity is nearing epidemic levels, with some research indicating an annual growth of 3-12%. Hence, the escalating rate of autoimmune disease will bolster the Humira drug market.

The humira drug market covered in this report is segmented –

1) By Type: Humira Syringe, Humira Pen

2) By Application: Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s Disease, Other Applications

3) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Humira Syringe: Pre-Filled Syringe, Disposable Syringe

2) By Humira Pen: Auto-Injector Pen, Pre-Filled Injection Pen

What Future Market Trends Are Projected For The Humira Drug Industry?

Product advancements are a significant trend in the humira drug market. Leading firms in this market are creating new biologics and biosimilars to maintain their market position. For example, Sandoz, a pharmaceutical company based in Switzerland, launched Biosimilar Hyrimoz (adalimumab), a citrate-free high-concentration formulation (HCF) in April 2023. This was approved by the European Commission. The adalimumab citrate-free HCF (100 mg/mL) formulation reduces the injection volume by 50% and decreases the number of necessary injections for patients needing doses of 80 mg/mL or higher. This is relevant to various conditions such as rheumatic diseases, Crohn’s disease, and others, providing an improved patient experience.

What Are The Most Active Companies In The Humira Drug Market Today?

Major companies operating in the humira drug market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Fresenius Kabi AG, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Sandoz International GmbH, Hikma Pharmaceuticals PLC, Celltrion Healthcare Co. Ltd., Cadila Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Mochida Pharmaceutical Co. Ltd., Innovent Biologics Inc., Biocad Biopharmaceutical Company, Shanghai Henlius Biotech Inc., Glenmark Pharmaceuticals Ltd., Samsung Bioepis Co Ltd., Hetero Healthcare Ltd., Coherus BioSciences Inc., CinnaGen Co., Alvotech Holdings S.A, Reliance Life Sciences Private Limited, Momenta Pharmaceuticals Inc., Bio-Thera Solutions Ltd., Fujifilm Kyowa Kirin Biologics Co. Ltd., BioXpress Therapeutics SA, Alteogen Inc., Prestige BioPharma Pte. Ltd.

https://www.thebusinessresearchcompany.com/report/humira-drug-global-market-report

Which Regional Markets Are Attracting The Most Investment In Humira Drug?

North America was the largest region in the humira drug market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the humira drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11934&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model